Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Creabilis
Creabilis
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
ChargePoint invest in a single-use manufacturing facility to expand product line
The single-use manufacturing facility will become fully operational in June 2024, and will support the company's trio of liquid and powder transfer devices
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
Bayer HealthCare and Johns Hopkins University to collaborate on new ophthalmic therapies
The partners will work jointly on the discovery and development of innovative drugs for the treatment of serious back-of-the-eye diseases
Berry Global invests to increase production capacity for healthcare products
Berry Global Group has invested in additional assets and manufacturing capabilities to increase its healthcare production capacity by up to 30% across three of its European sites
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Summit appoints Dr David Roblin as Chief Medical Officer
Roblin has been involved in the successful development of a number of important medicines in a range of therapy areas
Pharmaceutical
Creabilis appoints chief business officer
Dr Simon Russell joins the firm from Novartis
Finance
Creabilis establishes UK operation
Location in Kent broadens the county’s links with the pharma industry
Research & Development
Creabilis adds three executives to management team
Reflects growing confidence in pipeline and science that underpins it
Pharmaceutical
Creabilis hires chief medical officer
Dr David Roblin joins the firm after holding leading roles at Pfizer and Bayer
Research & Development
Creabilis appoints new chief executive
Eliot Forster brings significant drug development experience to firm
Pharmaceutical
Dermatology specialist appoints chairman
George Horner joins Creabilis of Luxembourg
Subscribe now